Biotechnology Stocks II: Compare Returns of S&P 500 to Xeris Biopharma Holdings, Inc. (XERS)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and XERS | ||
|---|---|---|
| S&P 500 | XERS | |
| Start Date | Aug-01-2018 | Jul-31-2018 |
| Start Price | $2,800.75 | $18.20 |
| End Date | Apr-11-2025 | Apr-17-2025 |
| End Price | $5,363.36 | $4.11 |
| Number Monthly Prices | 82 | 82 |
| Min Date | Dec-01-2018 | Jan-31-2023 |
| Min Price | $3,222.66 | $1.24 |
| Max Date | Dec-01-2024 | Aug-31-2018 |
| Max Price | $6,010.09 | $25.70 |
| Total Return | 50.05% | -77.42% |
| Annualized Return | 6.12% | -19.57% |
| Current Value of $1,000 Purchase | $1,501 | $226 |
| Number Returns | 3,321 | 3,321 |
| Average Return | 19.75% | -26.33% |
| Minimum Return | -25.54% | -95.18% |
| Maximum Return | 86.49% | 342.74% |
| Number Profitable Returns | 2,769 | 881 |
| Percent Profitable Returns | 83.38% | 26.53% |
| Number Unprofitable Returns | 552 | 2,440 |
| Percent Unprofitable Returns | 16.62% | 73.47% |
| Profitable to Unprofitable Returns Ratio | 5.02 | 0.36 |
XERS Dollar-cost Average
XERS Trendline Chart
XERS Moving Average Chart
XERS Stock Return Map - See Patterns of Gains and Losses
XERS Stock Returns/Purchase Dates